Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ)

Ruggiero, Salvatore L. (2007) Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Clinical cases in mineral and bone metabolism, 4 (1). pp. 37-42. ISSN 1971-3266

portiere.php.pdf - Published Version

Download (199kB)
Official URL:


Bisphosphonates are a class of agents used to treat osteoporosis and malignant bone metastases. Despite these benefits, osteonecrosis of the jaws has recently emerged as a significant complication in a subset of patients receiving these drugs. Based on a growing number of case reports and institutional reviews, bisphosphonate therapy may cause exposed and necrotic bone that is isolated to the jaw. This complication usually presents following simple dentoalveolar surgery and can cause a significant adverse effect on the quality of life for most patients. The pathogenesis for this complication appears to be related to the profound inhibition of osteoclast function and bone remodeling. This report will review the clinical signs and symptoms and risks associated with this new complication and provide a guideline for establishing a stage-specific diagnosis of BRONJ

Item Type: Article
Uncontrolled Keywords: Bisphosphonate-related osteonecrosis of the jaw, BRONJ, bisphosphonate associated osteonecrosis of the jaw, bisphosphonate, osteonecrosis of the jaw
Subjects: 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 612 Fisiologia umana > 612.7 Sistema muscoloscheletrico, tegumento
Depositing User: Danilo Dezzi
Date Deposited: 20 Jan 2014 10:22
Last Modified: 20 Jan 2014 10:22

Actions (login required)

View Item View Item